PerkinElmer Inc Stock News

The short answer: Increased demand for COVID-19 testing.

PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q4 2020 Results - Earnings Call Transcript

Shares of PerkinElmer (NYSE:PKI) moved higher by 0.1% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 193.33% over the past year to $3.96, whic

PerkinElmer (NYSE:PKI) unveils its next round of earnings this Tuesday, February 02. Here is Benzinga's everything-that-matters guide for the earnings announcement.

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is pa

Top Ranked Growth Stocks to Buy for January 27th

PerkinElmer's (PKI) fourth-quarter results are likely to reflect strong performance at Diagnostics segment.

PerkinElmer is absolutely on fire as preliminary fourth quarter results reveal. PerkinElmer is not a one-trick pony. It has been a long-term value creator for investors.

Top Ranked Growth Stocks to Buy for January 21st

PerkinElmer (PKI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

4 Stocks to Watch on Rising Demand for Scientific Instruments

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Top Ranked Growth Stocks to Buy for January 20th

Following are the three MedTech trends, which showed a steady momentum through the pandemic year and are likely to sustain even after the economic mayhem subsides.

PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.